Vision
Selectively targets RPE while preserving photoreceptors
R:GEN is the only retinal laser proven to deliver safe, efficacious and precise targeting of Retinal Pigment Epithelium (RPE) cells.
R:GEN’s proprietary Real-Time Feedback, Dual Dosimetry, and Auto Ramp-up technologies ensure precise targeting of RPE cells without damage to photoreceptors.
The R:GEN 527 nm laser with 1.7 μs pulse width provides ideal energy to selectively target the RPE cells while minimizing thermal damage.
R:GEN utilizes pioneering and proprietary technology to enhance clinical outcomes and safety.
R:GEN’s patented Dual Dosimetry Technology utilizes reflectomery (back-scattered light) and opto-acoustic signaling (thermoeleastic pressure waves) to precisely monitor the exact timing of RPE cell destruction. As a result, treatments even within the fovea become possible.
The proprietary Dual Dosimetry function works in tandem with automatic ramping of laser pulse energy. Incremental pulse energy ramping allow treatments to stop at the exact point of RPE cell destruction, and are therefore optimized for every patient and every treatment.
R:GEN selectively targets and causes mechanical disruption of RPE cells without damaging photoreceptors, resulting in the regeneration of new and healthy RPE cells. Rather than causing gross thermal damage to the neural retina, choroid, and photoreceptors, R:GEN triggers new cell growth and repair of function.
Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients